Diabetic Macular Edema in Diabetological Practices

Abstract

Using mobile OCT equipment and remote ophthalmological diagnosis of n = 1538 diabetics in 17 diabetes practices in Germany, we found diabetic macular edema in 10.1% of the patients and retinal bleedings or microaneurysms in 15.6%. In 1.62% of the diabetics examined, the size of the edema was > 0.4 mm², in 7% the retinal thickness was > 300 µm and thus in need of treatment. An intravitreal anti-VEGF injection was administered prior to the examination in only 10% of the patients with diabetic macular edema. By means of mobile tele-eye consultation and remote ophthalmological diagnosis using the cloud-based patient file certified as medical device IIa, patients with diabetic macular edema were identified and informed on site quickly and definitively. The data and images were made available to all attending physicians and ophthalmic surgeons.

Key words

diabetes - telediagnostics - tele-eye consultation - optical coherence tomography - diabetic macular edema - electronic patient file

Publication History

Received: 05 February 2020

Accepted: 06 May 2020

Article published online:
17 November 2020

• References/Literatur

• 1 Sabanayagam C, Yip W, Ting DS. et al.Wong TY. Ten Emerging Trends in the Epidemiology of Diabetic Retinopathy. Ophthalmic Epidemiol 2016; 23: 209-222
• 2 Ziemssen F, Lemmen K, Bertram B. et al. [National guidelines for treatment of diabetic retinopathy: second edition of the national guidelines for treatment of diabetic retinopathy]. Ophthalmologe 2016; 113: 623-638
• 3 Ulbig M, Höh H, Schmickler S. et al. POLARIS-Studiengruppe. [Treatment reality with ranibizumab in clinical routine use for patients with diabetic macular edema: 1-year results of the German POLARIS cohort]. Ophthalmologe 2019; 116: 631-639
• 4 Varma R, Bressler NM, Doan QV. et al. Prevalence of and risk factors for diabetic macular edema in the United States. JAMA Ophthalmol 2014; 132: 1334-1340
• 5 Weingessel B, Miháltz K, Gleiss A. et al. Treatment of diabetic macular edema with intravitreal antivascular endothelial growth factor and prompt versus deferred focal laser during long-term follow-up and identification of prognostic retinal markers. J Ophthalmol 2018; 2018: 3082560
• 6 Do DV, Nguyen QD, Vitti R. et al. Intravitreal aflibercept injection in diabetic macular edema patients with and without prior anti-vascular endothelial growth factor treatment: outcomes from the phase 3 program. Ophthalmology 2016; 123: 850-857
• 7 Bressler NM, Miller KM, Beck RW. et al. Diabetic Retinopathy Clinical Research Network. Observational study of subclinical diabetic macular edema. Eye (Lond) 2012; 26: 833-840
• 8 Glassman AR, Baker CW, Beaulieu WT. DRCR Retina Network. Assessment of the DRCR Retina Network approach to management with initial observation for eyes with center-involved diabetic macular edema and good visual acuity: a secondary analysis of a randomized clinical trial. JAMA Ophthalmol 2020; 138: 341-349